Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Breast Cancer
>
2019
>
22
>
2
Volume:
22
Issue:
2
1. Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer
Page:155—171
2. Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway
Page:172—184
3. Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway
Page:185—195
4. Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer
Page:196—209
5. The Correlation between IL-1β-C31T Gene Polymorphism and Susceptibility to Breast Cancer
Page:210—218
6. miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
Page:219—236
7. Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer
Page:237—247
8. High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
Page:248—259
9. Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer
Page:260—273
10. Murine Model Study of a New Receptor-Targeted Tracer for Sentinel Lymph Node in Breast Cancer
Page:274—284
11. The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
Page:285—296
12. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
Page:297—310
13. Comparison of Digital and Screen-Film Mammography for Breast-Cancer Screening: A Systematic Review and Meta-Analysis
Page:311—325
14. Solitary Fibrous Tumor of Breast with Anaplastic Areas (Malignant Solitary Fibrous Tumor): A Case Report with Review of Literature
Page:326—335
15. Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
Page:336—340